The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...

Wrist-worn devices can predict imminent inflammatory and symptomatic inflammatory bowel disease flare-ups as far in advance ...

In a large cohort of patients with autoimmune diseases, treatment with biologic disease-modifying antirheumatic drugs was ...

“Furthermore, these data strongly encourage us to pursue phase 2 clinical trials in other inflammatory indications including Crohn’s disease.” Ulcerative colitis is a debilitating ...

Women with inflammatory bowel disease who delivered a twin gestation pregnancy had higher rates of preterm delivery and ...

New Food's Ben Cornwell speaks with Reshma Patel about the gut health boom and how Yakult stays ahead in the growing ...

Research analysts at William Blair decreased their FY2025 earnings per share (EPS) estimates for shares of AbbVie in a note ...

The pharmaceutical industry could generate more than $1.2 trillion in global sales in 2025, according to Statista. The cancer segment alone is expected to generate $208 billion in sales this year. The ...

Marijuana legislation is continuing to evolve in the new year across jurisdictions throughout the U.S. Below, we dive into a ...

As if having erectile dysfunction wasn’t, erm, hard enough, scientists said impotence may be linked to a common condition ...

Overall, the use of 5-aminosalicylic acid (5-ASA) in combination with ustekinumab (UST) did not provide a significant benefit in patients with inflammatory bowel disease (IBD). Evidence Rating Level: ...

Ultra-processed foods are convenient choices, but studies are showing they have a negative impact on health. Learn what they ...